Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-061545

President and CEO gave up 743 shares (to pay taxes)

  • President and CEO acquired 2,925 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Walker Neal President and CEO 2019-12-18 Option exercise +2,925 922,521 D
Walker Neal President and CEO 2019-12-18 Shares withheld for taxes −743 $1.81 $1,345 921,778 D
Derivatives
Walker Neal President and CEO 2019-12-18 Option exercise · Restricted Stock Units −2,925 0 D
Loading xslF345X03/doc4.xml…